Cargando…
Changing Patterns in Clinicopathological Characteristics of Breast Cancer and Prevalence of BRCA Mutations: Analysis in a Rural Area of Southern China
PURPOSE: Although the burden of breast cancer remains especially high in rural China, data on the clinicopathological characteristics and prevalence of the breast cancer susceptibility gene 1/2 (BRCA1/2) mutations in patients with breast cancer remain limited. We investigated the clinicopathological...
Autores principales: | Wang, Qiuming, Wu, Heming, Lan, Yongquan, Zhang, Jinhong, Wu, Jingna, Zhang, Yunuo, Li, Liang, Liu, Donghua, Zhang, Jinfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565898/ https://www.ncbi.nlm.nih.gov/pubmed/34744450 http://dx.doi.org/10.2147/IJGM.S333858 |
Ejemplares similares
-
Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
por: Zhang, Yunuo, et al.
Publicado: (2022) -
Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer
por: Ye, Min, et al.
Publicado: (2021) -
lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p
por: Zhang, Jinfeng, et al.
Publicado: (2021) -
GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients
por: Zeng, Juanzi, et al.
Publicado: (2022) -
The Features of BRCA1 and BRCA2 Germline Mutations in Hakka Ovarian Cancer Patients: BRCA1 C.536 A>T Maybe a Founder Mutation in This Population
por: Luo, Yu, et al.
Publicado: (2022)